E A Voss1, R D Boyce2, P B Ryan3, J van der Lei4, P R Rijnbeek4, M J Schuemie5. 1. Epidemiology Analytics, Janssen Research & Development, LLC, Raritan, NJ, United States; Erasmus University Medical Center, Rotterdam, Netherlands; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States. Electronic address: evoss3@its.jnj.com. 2. University of Pittsburgh, Pittsburgh, PA, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States. 3. Epidemiology Analytics, Janssen Research & Development, LLC, Raritan, NJ, United States; Columbia University, New York, NY, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States. 4. Erasmus University Medical Center, Rotterdam, Netherlands; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States. 5. Epidemiology Analytics, Janssen Research & Development, LLC, Raritan, NJ, United States; Observational Health Data Sciences and Informatics (OHDSI), New York, NY, United States.
Abstract
INTRODUCTION: Drug safety researchers seek to know the degree of certainty with which a particular drug is associated with an adverse drug reaction. There are different sources of information used in pharmacovigilance to identify, evaluate, and disseminate medical product safety evidence including spontaneous reports, published peer-reviewed literature, and product labels. Automated data processing and classification using these evidence sources can greatly reduce the manual curation currently required to develop reference sets of positive and negative controls (i.e. drugs that cause adverse drug events and those that do not) to be used in drug safety research. METHODS: In this paper we explore a method for automatically aggregating disparate sources of information together into a single repository, developing a predictive model to classify drug-adverse event relationships, and applying those predictions to a real world problem of identifying negative controls for statistical method calibration. RESULTS: Our results showed high predictive accuracy for the models combining all available evidence, with an area under the receiver-operator curve of ⩾0.92 when tested on three manually generated lists of drugs and conditions that are known to either have or not have an association with an adverse drug event. CONCLUSIONS: Results from a pilot implementation of the method suggests that it is feasible to develop a scalable alternative to the time-and-resource-intensive, manual curation exercise previously applied to develop reference sets of positive and negative controls to be used in drug safety research. Copyright Â
INTRODUCTION: Drug safety researchers seek to know the degree of certainty with which a particular drug is associated with an adverse drug reaction. There are different sources of information used in pharmacovigilance to identify, evaluate, and disseminate medical product safety evidence including spontaneous reports, published peer-reviewed literature, and product labels. Automated data processing and classification using these evidence sources can greatly reduce the manual curation currently required to develop reference sets of positive and negative controls (i.e. drugs that cause adverse drug events and those that do not) to be used in drug safety research. METHODS: In this paper we explore a method for automatically aggregating disparate sources of information together into a single repository, developing a predictive model to classify drug-adverse event relationships, and applying those predictions to a real world problem of identifying negative controls for statistical method calibration. RESULTS: Our results showed high predictive accuracy for the models combining all available evidence, with an area under the receiver-operator curve of ⩾0.92 when tested on three manually generated lists of drugs and conditions that are known to either have or not have an association with an adverse drug event. CONCLUSIONS: Results from a pilot implementation of the method suggests that it is feasible to develop a scalable alternative to the time-and-resource-intensive, manual curation exercise previously applied to develop reference sets of positive and negative controls to be used in drug safety research. Copyright Â
Authors: Rave Harpaz; Alison Callahan; Suzanne Tamang; Yen Low; David Odgers; Sam Finlayson; Kenneth Jung; Paea LePendu; Nigam H Shah Journal: Drug Saf Date: 2014-10 Impact factor: 5.606
Authors: Gianluca Trifiro; Annie Fourrier-Reglat; Miriam C J M Sturkenboom; Carlos Díaz Acedo; Johan Van Der Lei Journal: Stud Health Technol Inform Date: 2009
Authors: Rachel E Behrman; Joshua S Benner; Jeffrey S Brown; Mark McClellan; Janet Woodcock; Richard Platt Journal: N Engl J Med Date: 2011-01-12 Impact factor: 91.245
Authors: Paul Avillach; Jean-Charles Dufour; Gayo Diallo; Francesco Salvo; Michel Joubert; Frantz Thiessard; Fleur Mougin; Gianluca Trifirò; Annie Fourrier-Réglat; Antoine Pariente; Marius Fieschi Journal: J Am Med Inform Assoc Date: 2012-11-29 Impact factor: 4.497
Authors: Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema Journal: Drug Saf Date: 2013-10 Impact factor: 5.606
Authors: Preciosa M Coloma; Paul Avillach; Francesco Salvo; Martijn J Schuemie; Carmen Ferrajolo; Antoine Pariente; Annie Fourrier-Réglat; Mariam Molokhia; Vaishali Patadia; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifirò Journal: Drug Saf Date: 2013-01 Impact factor: 5.606
Authors: Juan M Banda; Lee Evans; Rami S Vanguri; Nicholas P Tatonetti; Patrick B Ryan; Nigam H Shah Journal: Sci Data Date: 2016-05-10 Impact factor: 6.444
Authors: Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak Journal: Harv Data Sci Rev Date: 2020-01-31
Authors: Martijn J Schuemie; George Hripcsak; Patrick B Ryan; David Madigan; Marc A Suchard Journal: Proc Natl Acad Sci U S A Date: 2018-03-13 Impact factor: 11.205
Authors: Seng Chan You; Yeunsook Rho; Behnood Bikdeli; Jiwoo Kim; Anastasios Siapos; James Weaver; Ajit Londhe; Jaehyeong Cho; Jimyung Park; Martijn Schuemie; Marc A Suchard; David Madigan; George Hripcsak; Aakriti Gupta; Christian G Reich; Patrick B Ryan; Rae Woong Park; Harlan M Krumholz Journal: JAMA Date: 2020-10-27 Impact factor: 56.272
Authors: Marc A Suchard; Martijn J Schuemie; Harlan M Krumholz; Seng Chan You; RuiJun Chen; Nicole Pratt; Christian G Reich; Jon Duke; David Madigan; George Hripcsak; Patrick B Ryan Journal: Lancet Date: 2019-10-24 Impact factor: 79.321